about
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits f...
Read More
47.20
0.70
(1.51%)
2.2M
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Sanofi (ADR) is on 30 Jan 2026 for the purpose of Sanofi SA Fourth Quarter Earnings Results for 2025
See details
High Financial Strength
Affordable Valuation
Technically Bearish
Value Stock, Under Radar
These stocks score high in quality and valuation, but medium in technicals. Investors may want to wait for the stock to improve momentum
View Similar
Embed DVM
Sanofi (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..